# Neoadjuvant Chemotherapy in Cervical Cancer

> **NCT05384366** · PHASE3 · COMPLETED · sponsor: **Banaras Hindu University** · enrollment: 33 (actual)

## Conditions studied

- Cervix Cancer
- Cervical Cancer
- Cancer of the Uterine Cervix

## Interventions

- **DRUG:** Neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT05384366
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384366, "Neoadjuvant Chemotherapy in Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05384366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*